At ADA, Breakthrough T1D-Funded Research Takes Center Stage (with a “Happy Hour” by Dr. Aaron Kowalski)
At the ADA’s Scientific Sessions, Breakthrough T1D scientists presented on some of the most important topics, all with the same…
Breakthrough T1D Heads—In Person!—to ADA’s 82nd Scientific Sessions
From June 3-7, diabetes researchers around the world will gather—in person!—at the American Diabetes Association’s 82nd Scientific Sessions. #JDRFxADA
FDA Approved! Abbott FreeStyle Libre® 3 Continuous Glucose Monitor, Ages 4+
The FDA cleared the FreeStyle Libre 3 continuous glucose monitor (CGM) for children and adults ages 4 and up with diabetes
Moonshot Reimagined: Our Vision to Halt and Reverse Vision Loss
Breakthrough T1D has taken a bold new step to prevent and restore vision loss and blindness: Restoring Vision Moonshot, in…
100, 100: Ending Diabetic Eye Disease, Forever
Breakthrough T1D has supported eye disease research since its beginning, and has driven discoveries that have reduced the risk of…
Breakthrough T1D Video: No Health Without Mental Health
Find out why we absolutely love psychologist Jill Weissberg-Benchell.
Top Researchers Gather for the 15th ATTD Conference
Leading researchers gathered, in person, for the annual meeting of the ATTD Conference (April 27-30), featuring 30+ studies presented by…
An Enemy You Can Beat: T1D in Video Games
We're continuing that trend by putting the spotlight on video games and game developers with links to T1D.
Vertex Provides an Update on the VX-880 Clinical Trial
Vertex provides an update on their Phase 1/2 Clinical Trial for VX-880, including data from three participants and details around…
ATTD Conference Brings Together Top Minds in Diabetes Research
Diabetes researchers from all over the world gather for the ATTD Conference, which will take place in-person and online from…
